5- (4- (2- (3,4,5- trimethoxyphenyl)ethyl)phenyl)- 2,3- dihydroimidazo(1,2a)thieno(2,3- c)pyridine
structure given in first source; platelet activating factor antagonist
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results